Typhoid Fever Vaccines Market to Grow at 9.3% CAGR During 2020 to 2027 – The Insight Partners

According to our new market research study on “Typhoid fever vaccines Market to 2027 – Global Analysis and Forecast – by vaccine type and route of administration,” the market is expected to reach US$ 525.32 million by 2027 from US$ 262.81 million in 2019. The market is estimated to grow with a CAGR of 9.3% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Typhoid is an infectious diseases caused due to contaminated food and water. Typhoid is a bacterial infection that can lead to a high fever and it is caused by the bacteria Salmonella typhi. This disease is rare in developed countries and vaccines are recommended in the areas where the disease is prevalent. There are two types of vaccines to prevent typhoid fever. One is an inactivated (killed) vaccine and the other is a live, attenuated (weakened) typhoid fever vaccine. Inactivated typhoid vaccine is administered as an injection.

The scope of the Typhoid fever vaccines market includes procedure Typhoid fever vaccines type, route of administration, and region. The market for Typhoid fever vaccinesis analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the Typhoid fever vaccines market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

Request for sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00003752/

Typhoid fever vaccines Market Competitive Landscape

Shanghai institute of biological products co., ltd., Bharat Biotech, Sanofi, GlaxoSmithKline, Paxvax Inc., PT Bio Farma, BIO-MED, Prokarium Ltd., Scandinavian Biopharma are among the leading companies operating in the Typhoid fever vaccines market.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world’s children below the 5-year-old age group.

Growing Number of Patients Suffering with Typhoid

Typhoid fever refers to a systemic infection caused by Salmonella Typhi that is usually ingested through contaminated water or food. The infectious disease is usually caused predominantly in association with lack of clean water and poor sanitization. Typhoid is known to be the most common fever in rural and underdeveloped economies. According to the recent estimates of the World Health Organization (WHO), typhoid is an endemic fever in Africa, Asia, Latin America, Oceania, and the Caribbean. The WHO also states that 80% of the typhoid fever cases arise from India, Bangladesh, China, Laos, Nepal, Indonesia, Vietnam, and Pakistan. As per the recent study by All India Institute of Medical Sciences (AIIMS), around 494 per 100,000 children of age group 5–15 years suffered from typhoid in 2017.

According to the Centers for Disease Control and Prevention (CDC), most of the typhoid fever cases in the US arise among international travelers. According to a study published in Lancet: Infectious Diseases, typhoid infects ~21.6 million people worldwide and is responsible for the deaths of estimated 200,000 people each year. Further, the economic instability in Latin America and some of the other underdeveloped economies have led to improper sanitation and limited access to clean water and food, which is leading to a high risk of typhoid incidence. According to the National Health Services (NHS), children experience the highest risk of typhoid infection worldwide due to growing stage of immunity among children.

Typhoid fever vaccines Market Segmentation Review

Global Typhoid fever vaccines Market, based on Typhoid fever vaccines type, the Typhoid fever vaccines market is segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. In 2019, the capsular polysaccharide vaccinessegment accounted for the highest share of the market. Growth of this segment is attributed to the effectiveness associated with in preventing infectionsand increasing patient pool across the globe. The Live Attenuated Vaccine segment is likely to register highest CAGR in the global Typhoid fever vaccines market during the forecast period.

Global Typhoid fever vaccines Market, based on route of administration, the Typhoid fever vaccines market is segmented into oral and injections. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR of 10.1% in the market during the forecast period.

Buy Complete Report of Typhoid fever vaccines Market at: https://www.theinsightpartners.com/buy/TIPRE00003752/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

E-mail: sales@theinsightpartners.com


Phone: +1-646-491-9876



Back to news